2017
DOI: 10.1016/j.resuscitation.2017.04.036
|View full text |Cite
|
Sign up to set email alerts
|

The cost-effectiveness of a mechanical compression device in out-of-hospital cardiac arrest

Abstract: Our study demonstrates that the use of the mechanical chest compression device LUCAS-2 represents poor value for money when compared to standard manual chest compression in out-of-hospital cardiac arrest.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0
2

Year Published

2018
2018
2020
2020

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(17 citation statements)
references
References 35 publications
0
15
0
2
Order By: Relevance
“… 19–22 Moreover, an analysis of the cost-effectiveness of the use of mechanical compression devices in OHCA showed that they were more costly and less effective than manual chest compressions. 23 Therefore, further studies are needed to evaluate the routine use of mechanical devices in OHCA.…”
Section: Discussionmentioning
confidence: 99%
“… 19–22 Moreover, an analysis of the cost-effectiveness of the use of mechanical compression devices in OHCA showed that they were more costly and less effective than manual chest compressions. 23 Therefore, further studies are needed to evaluate the routine use of mechanical devices in OHCA.…”
Section: Discussionmentioning
confidence: 99%
“…The long-term (up to 12 months) outcome analysis found no clinically important differences between groups in relation to outcomes such as survival, neurological outcome, and quality of life at 3 months and 12 months, although the analysis was subject to a high risk of attrition bias [ 24 ]. The cost-effectiveness analysis found that routine use of mechanical CPR devices in the out-of-hospital setting was not cost-effective [ 25 ].…”
Section: Introductionmentioning
confidence: 99%
“…Trial recruitment ran from 15 April 2010 to 10 June 2013. We have previously reported primary outcome (30-day survival), 10 secondary outcomes, 11 an economic analysis 12 and characteristics of patients who were not resuscitated. 13 …”
Section: Methodsmentioning
confidence: 99%
“…We used the MINAP, NAPCI and CMP data for the health economic analysis 12 and long-term postadmission outcomes 11 and to validate the hospital length of stay or stay in the intensive care (secondary outcomes for the efficacy part of the trial) and also to gain insight into the specifics of the treatment or procedures that trial patients received during their hospital stay. Characteristics of the registries are summarised in table 1 .…”
Section: Methodsmentioning
confidence: 99%